Beate Appenrodt

4.1k total citations · 1 hit paper
41 papers, 2.4k citations indexed

About

Beate Appenrodt is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Beate Appenrodt has authored 41 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hepatology, 32 papers in Epidemiology and 17 papers in Surgery. Recurrent topics in Beate Appenrodt's work include Liver Disease and Transplantation (33 papers), Liver Disease Diagnosis and Treatment (30 papers) and Organ Transplantation Techniques and Outcomes (13 papers). Beate Appenrodt is often cited by papers focused on Liver Disease and Transplantation (33 papers), Liver Disease Diagnosis and Treatment (30 papers) and Organ Transplantation Techniques and Outcomes (13 papers). Beate Appenrodt collaborates with scholars based in Germany, United States and Spain. Beate Appenrodt's co-authors include Tilman Sauerbruch, Karel Caca, Juan Carlos García‐Pagán, Juan G. Abraldeṣ, Wim Laleman, Jaime Bosch, Angelo Luca, Frederik Nevens, Jean Pierre Vinel and Christophe Bureau and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and PLoS ONE.

In The Last Decade

Beate Appenrodt

39 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early Use of TIPS in Patients with Cirrhosis and Variceal Bleeding

2010 768 citations Juan Carlos García‐Pagán, Karel Caca et al. profile →

Peers

Beate Appenrodt

HEPAT

EPIDE

SURGE

NEPHR

PRM

Lluçia Titó Spain

Kenneth A. Somberg United States

AK Burroughs United Kingdom

Juan Rodés Spain

Jeffrey M. Rank United States

G. Clemente Spain

Josep Terés Spain

Silvia Martini Italy

Jean Pierre Vinel France

Roberto de Franchis Italy

Lluçia Titó Spain

Beate Appenrodt

1.3k ×0.6

HEPAT

1.0k ×0.6

EPIDE

830 ×0.6

SURGE

164 ×0.9

NEPHR

288 ×1.7

PRM

Citations per year, relative to Beate Appenrodt Beate Appenrodt (= 1×) peers Lluçia Titó

Countries citing papers authored by Beate Appenrodt

Since Specialization

Citations

This map shows the geographic impact of Beate Appenrodt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beate Appenrodt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beate Appenrodt more than expected).

Fields of papers citing papers by Beate Appenrodt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beate Appenrodt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beate Appenrodt. The network helps show where Beate Appenrodt may publish in the future.

Co-authorship network of co-authors of Beate Appenrodt

This figure shows the co-authorship network connecting the top 25 collaborators of Beate Appenrodt. A scholar is included among the top collaborators of Beate Appenrodt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beate Appenrodt. Beate Appenrodt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Appenrodt, Beate & Frank Lammert. (2018). Renal Failure in Patients with Liver Cirrhosis: Novel Classifications, Biomarkers, Treatment. Visceral Medicine. 34(4). 246–252. 16 indexed citations

Lammert, Frank, et al.. (2018). Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study. PLoS ONE. 13(2). e0192271–e0192271. 15 indexed citations

Bruns, Tony, Philipp A. Reuken, Sven Stengel, et al.. (2016). The prognostic significance of bacterial DNA in patients with decompensated cirrhosis and suspected infection. Liver International. 36(8). 1133–1142. 34 indexed citations

Lutz, Philipp, Benjamin Krämer, Dominik J. Kaczmarek, et al.. (2015). A variant in the nuclear dot protein 52kDa gene increases the risk for spontaneous bacterial peritonitis in patients with alcoholic liver cirrhosis. Digestive and Liver Disease. 48(1). 62–68. 9 indexed citations

Kreisel, Wolfgang, Peter Deibert, Limas Kupčinskas, et al.. (2014). The phosphodiesterase-5-inhibitor udenafil lowers portal pressure in compensated preascitic liver cirrhosis. A dose-finding phase-II-study. Digestive and Liver Disease. 47(2). 144–150. 39 indexed citations

García‐Pagán, Juan Carlos, Marco Di Pascoli, Karel Caca, et al.. (2012). Use of early-TIPS for high-risk variceal bleeding: Results of a post-RCT surveillance study. Journal of Hepatology. 58(1). 45–50. 176 indexed citations

Laleman, Wim, Marco Di Pascoli, K Caca, et al.. (2012). Use of EARLY TIPS for high risk variceal bleeding. Results of a post-RCT surveillance study. Acta gastro-enterologica belgica. 75(1). 1 indexed citations

Nischalke, Hans Dieter, F Grünhage, Frank Lammert, et al.. (2011). Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis. Journal of Hepatology. 55(5). 1010–1016. 77 indexed citations

Gerbes, Alexander L., Veit Gülberg, Tilman Sauerbruch, et al.. (2011). S3-Leitlinie „Aszites, spontan bakterielle Peritonitis, hepatorenales Syndrom”. Zeitschrift für Gastroenterologie. 49(6). 749–779. 60 indexed citations

10.

Boyer, Thomas, Arun J. Sanyal, Guadalupe García–Tsao, et al.. (2011). Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1. Liver Transplantation. 17(11). 1328–1332. 84 indexed citations

11.

Appenrodt, Beate, Lutz Lehmann, Christian Rabe, et al.. (2010). Is detection of bacterial DNA in ascitic fluid of clinical relevance?. European Journal of Gastroenterology & Hepatology. 22(12). 1487–1494. 24 indexed citations

12.

Appenrodt, Beate, et al.. (2009). Degree of hepatic dysfunction and improvement of renal function predict survival in patients with HRS type I: a retrospective analysis. European Journal of Gastroenterology & Hepatology. 21(12). 1428–1432. 13 indexed citations

13.

Appenrodt, Beate, et al.. (2009). Nucleotide‐binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis†. Hepatology. 51(4). 1327–1333. 94 indexed citations

14.

Rabe, Christian, Beate Appenrodt, Christian Hoff, et al.. (2009). Severe respiratory failure due to diffuse alveolar hemorrhage: Clinical characteristics and outcome of intensive care. Journal of Critical Care. 25(2). 230–235. 41 indexed citations

15.

Schepke, Michael, et al.. (2009). Coexisting Gastric Varices Should Not Preclude Prophylactic Ligation of Large Esophageal Varices in Cirrhosis. Digestion. 80(3). 165–169. 3 indexed citations

16.

Quante, Michael, et al.. (2008). Atypical Ormond's disease associated with bile duct stricture mimicking cholangiocarcinoma. Scandinavian Journal of Gastroenterology. 44(1). 116–120. 6 indexed citations

17.

Appenrodt, Beate & Tilman Sauerbruch. (2007). Antibiotische Therapie und Prophylaxe bei Leberzirrhose und Infektion. DMW - Deutsche Medizinische Wochenschrift. 132(12). 623–626. 1 indexed citations

18.

Appenrodt, Beate, et al.. (2006). A patient with portal hypertension and blindness after transjugular intrahepatic portosystemic shunt. European Journal of Gastroenterology & Hepatology. 18(4). 447–449. 8 indexed citations

19.

Schepke, Michael, et al.. (2006). Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD: results of a prospective study. Liver International. 26(7). 834–839. 50 indexed citations

20.

Biecker, Erwin, et al.. (2005). Die intestinale Blutung bei portaler Hypertension bei Leberzirrhose. Zeitschrift für Gastroenterologie. 43(1). 35–46. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact